Abstract
As the practice of cellular therapy grows, the decision must be made as to whether a clinical entity, such as that in an academic institution, or stand-alone hospital, wishes to build a cell processing facility to provide the products. An alternative is to use commercial companies for cell processing and/or testing. In recent years, a number of such entities have appeared, and this chapter addresses some of the factors that are involved in selecting those which can meet your needs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
U.S. Food and Drug Administration (2008) Current good manufacturing practice for phase 1 investigational drugs. Guidance for Industry. July 2008. https://www.fda.gov/media/70975/download. Last accessed 13 July 2020.
U.S. Food and Drug Administration (2016) Contract manufacturing arrangements for drugs: Quality agreements guidance for industry. November 2016. https://www.fda.gov/media/86193/download. Last accessed 13 July 2020.
Cell Trials Data Website. Cell and gene therapy CMO and CDMO facilities. https://celltrials.org/public-cells-data/cell-and-gene-therapy-cmo-and-cdmo-facilities/72. Last accessed 13 July 2020.
Center for Commercialization of Regenerative Medicine website. https://www.ccrm.ca/. Last accessed 13 July 2020.
Biopharm International website. The Outlook for CMO Outsourcing in 2019. http://www.biopharminternational.com/outlook-cmo-outsourcing-2019. Last accessed 13 July 2020.
Businesswire website. Biopharmaceutical CMO & CRO Market Size Analysis Report By Source, By Service Type (Contract Manufacturing, Contract Research), By Product (Biologics, Biosimilars), and Segment Forecasts, 2019–2025″. https://www.businesswire.com/news/home/20190626005691/en/Global-Biopharmaceutical-CMO-CRO-Markets-2019-2025-Service. Last accessed 13 July 2020.
Businesswire website. Stem cell therapy contract manufacturing market, 2030 – ResearchAndMarkets,com. https://www.businesswire.com/news/home/20191203005513/en/Stem-Cell-Therapy-Contract-Manufacturing-Market-2030 Last accessed 13 July 2020.
Boyds Consultants website. The critical role of a CMO in advanced therapy clinical and commercial product manufacture. https://www.boydconsultants.com/role-of-cmo-in-atmp-manufacture/. Last accessed 13 July 2020.
U.S. Food and Drug Administration. INTERACT Meetings (Initial Targeted Engagement for Regulatory Advice on CBER products). https://www.fda.gov/vaccines-blood-biologics/industry-biologics/interact-meetings-initial-targeted-engagement-regulatory-advice-cber-products. Last accessed 13 July 2020.
U.S. Food and Drug Administration (2020) Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs) Guidance for Industry. January 2020. https://www.fda.gov/media/113760/download. Last accessed 13 July 2020.
U.S. Food and Drug Administration (2008) Content and review of chemistry, Manufacturing, and Control (CMC) Information for Human Somatic Cell Therapy Investigational New Drug Applications (INDs). Guidance for FDA Reviewers and Sponsors. April 2008. https://www.fda.gov/media/73624/download. Last accessed 13 July 2020.
Pharmaceutical Technology website (2019) Gene-ie in a bottle’ gene therapy opportunity is a treasure trove but CMOs lack capacity. https://www.pharmaceutical-technology.com/comment/gene-therapy-cmo-capacity/. Last accessed 13 July 2020.
Acknowledgments
This work was supported in part by a Core grant (RP180785) from the Cancer Research and Prevention Institute of Texas.
I would like to thank Sara Richman of the Center for Cell and Gene Therapy for reviewing this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gee, A.P., Lyon, D. (2022). Selection of Contract Manufacturing and Testing Organizations. In: Gee, A.P. (eds) Cell Therapy. Springer, Cham. https://doi.org/10.1007/978-3-030-75537-9_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-75537-9_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-75535-5
Online ISBN: 978-3-030-75537-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)